NVCR - Novocure Tumor Treating Fields decreases progression of brain metastases
2024-06-03 12:42:41 ET
More on NovoCure
- NovoCure Limited Q1 Earnings: Core Business Accelerating
- NovoCure Limited (NVCR) Q1 2024 Earnings Call Transcript
- NovoCure Limited 2024 Q1 - Results - Earnings Call Presentation
- Novocure secures new $400M multi-tranche debt financing, shares up
- NovoCure GAAP EPS of -$0.36 beats by $0.06, revenue of $138.5M beats by $7.05M